1. Scrip
  2. >>Archive

Competence And Fairness At One Of Europe’s Dynamic API Producers

Don’t miss an inside look at how CF Pharma and its subsidiary, Pátriapharma, have successfully leveraged innovation and a focus on competence and fairness to be a leading CMO and generic API producer. Discover how CF Pharma has come to stand for “competent and fair” in the company’s approach to its business practices, products, and people.

Competence And Fairness At One Of Europe’s Dynamic API Producers | pdf

Don’t miss your free article from Pharma Ignite, presented in partnership with CF Pharma.

Read this article and learn how CF Pharma:

  • Is effectively addressing API supply chain issues
  • Embraces innovative solutions as part of their environmental, social, and governance (ESG) philosophy
  • Emphasizes safety and sustainability as part of their processes
  • Maintains a focus on a culture of quality
  • Innovates within their R&D teams
  • Has recently moved into providing intermediates

More from Archive

Final Chance To Have Your Say: Take Scrip's Reader Survey This Week

 
• By Eleanor Malone

Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.

Shape Our Content: Take The Reader Survey

 
• By Eleanor Malone

Editor’s note: We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in the coverage topics, content format or the method in which you receive and access Scrip, or if you love it how it is, now is the time to have your voice heard.

Galapagos Expands Point-Of-Care CAR-T Study To The US

 
• By Andrew McConaghie

CEO Paul Stoffels said gaining US clearance for an IND for its novel CAR-T product was demanding, but now opens up a pathway towards a pivotal study starting in 2025.

Analysts Split On Eisai’s Chances Of Changing EU Regulator’s Mind On Leqembi

 
• By Andrew McConaghie

A final rejection of Leqembi could also spell the same fate for Lilly’s rival drug but public outcry and demand for Alzheimer’s therapies might force the regulator’s hand

More from Scrip

In partnership with

Podcast: Strategic Insights into the RNA Market

Discover the latest trends in RNA-based therapeutics and learn how sponsors can successfully navigate the road to next generation innovation. Listen in as Citeline chats with the Director of Therapeutics at Novotech, a CRO experienced in RNA development.

In partnership with

Building a Stronger Pharma Industry for Patients and Providers

Learn more about the challenges faced by today’s drug developers and the critical factors to consider as sponsors navigate the supply chain, keep up with regulatory requirements, and ensure patient access. Discover more about the role of generics and how Aspire Pharma can help.

In partnership with

Podcast Series: Navigating Regulatory & Market Shifts — CRO Perspectives on Clinical Trials

Insights from Novotech on Evolving Trends Impacting Global Clinical Development

In partnership with

Podcast: Navigating the Future of Hepatology Clinical Trials

Join Andrew Warmington, Manufacturing Editor at Citeline, in conversation with Tom Hickey, Director of Therapeutic Strategy at Novotech, a global full-service clinical CRO dedicated to accelerating the development of advanced and novel therapeutics.